• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性植入后高初始心外膜补片除颤阈值的消退

Resolution of high initial epicardial patch defibrillation thresholds following chronic implantation.

作者信息

Grubb B P, Mancini M, Temesy-Armos P, Hahn H, Elliott L

机构信息

Division of Cardiology, Medical College of Ohio, Toledo 43699.

出版信息

Pacing Clin Electrophysiol. 1991 Feb;14(2 Pt 1):149-51. doi: 10.1111/j.1540-8159.1991.tb05082.x.

DOI:10.1111/j.1540-8159.1991.tb05082.x
PMID:1706497
Abstract

To determine what effect chronic implantation of automatic implantable cardioverter defibrillator epicardial patch electrodes had on initial high defibrillation thresholds at implant, six patients were studied. There were five men, one woman, mean age 61 years. Three had coronary artery disease and three had dilated cardiomyopathies. Mean ejection fraction was 20%. Two patients underwent concomitant coronary artery revascularization and one underwent mitral valve replacement. No patient was on antiarrhythmic drugs. At the time of initial implant, adequate defibrillating thresholds could not be obtained in any patch configuration despite the use of up to 40 joules. Further testing was precluded in each patient due to the development of profound hypotension (less than or equal to 70 mmHg systolic) that was poorly responsive to pressors. The patch electrodes were then implanted in an arbitrary anterior-posterior position and the leads were tunneled to an abdominal pocket. After 10-15 days (mean 11), the lead ends were exposed and defibrillation testing was performed again. In all six patients, adequate defibrillation thresholds were obtained (mean 18 joules). We conclude that if adequate defibrillation thresholds cannot be obtained at implant and if further testing cannot be performed without jeopardizing the life of the patient, the patch electrodes should be implanted and retesting performed at 10-15 days.

摘要

为了确定自动植入式心脏复律除颤器的心外膜贴片电极长期植入对植入时初始高除颤阈值有何影响,对6例患者进行了研究。其中男性5例,女性1例,平均年龄61岁。3例患有冠状动脉疾病,3例患有扩张型心肌病。平均射血分数为20%。2例患者同时接受了冠状动脉血运重建术,1例接受了二尖瓣置换术。所有患者均未服用抗心律失常药物。在初次植入时,尽管使用了高达40焦耳的能量,任何贴片配置均未获得足够的除颤阈值。由于出现严重低血压(收缩压小于或等于70mmHg)且对升压药反应不佳,每位患者均未进行进一步测试。然后将贴片电极以任意前后位置植入,并将导线经皮下隧道引至腹部囊袋。10 - 15天后(平均11天),暴露导线末端并再次进行除颤测试。在所有6例患者中均获得了足够的除颤阈值(平均18焦耳)。我们得出结论,如果在植入时无法获得足够的除颤阈值,并且如果不危及患者生命就无法进行进一步测试,则应植入贴片电极并在10 - 15天后重新进行测试。

相似文献

1
Resolution of high initial epicardial patch defibrillation thresholds following chronic implantation.慢性植入后高初始心外膜补片除颤阈值的消退
Pacing Clin Electrophysiol. 1991 Feb;14(2 Pt 1):149-51. doi: 10.1111/j.1540-8159.1991.tb05082.x.
2
Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.使用带有三电极系统的植入式心脏复律除颤器进行心内膜除颤的初步临床经验。
Arch Intern Med. 1989 Oct;149(10):2333-9.
3
Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.新型植入式起搏除颤器所提供的自动多模式设备治疗室性快速心律失常的疗效。一项欧洲多中心研究(涉及102例植入)的结果
Circulation. 1992 Aug;86(2):363-74. doi: 10.1161/01.cir.86.2.363.
4
A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation.一种用于植入式起搏器心脏复律除颤器的永久性经静脉导线系统。非开胸植入方法。
Circulation. 1992 Jan;85(1):196-204. doi: 10.1161/01.cir.85.1.196.
5
Ventricular pacing threshold and time to capture postdefibrillation in patients undergoing implantable cardioverter-defibrillator implantation.接受植入式心脏复律除颤器植入术患者的心室起搏阈值及除颤后夺获时间
Pacing Clin Electrophysiol. 1991 May;14(5 Pt 1):768-72. doi: 10.1111/j.1540-8159.1991.tb04104.x.
6
Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator.慢性除颤的成功以及抗心律失常药物在植入式自动心脏复律除颤器中的作用。
Am J Cardiol. 1987 Nov 1;60(13):1061-4. doi: 10.1016/0002-9149(87)90352-3.
7
Late results of the left subcostal approach for automatic implantable cardioverter defibrillator implantation.经左肋下途径植入自动植入式心脏复律除颤器的远期结果。
Am J Cardiol. 1991 Feb 15;67(5):387-90. doi: 10.1016/0002-9149(91)90047-o.
8
Management of complications associated with a first-generation endocardial defibrillation lead system for implantable cardioverter-defibrillators.第一代植入式心脏复律除颤器心内膜除颤导线系统相关并发症的管理
Am J Cardiol. 1990 Aug 15;66(4):411-5. doi: 10.1016/0002-9149(90)90695-w.
9
[Clinical experience with a second-generation cardioverter-defibrillator].[第二代心脏复律除颤器的临床经验]
Schweiz Med Wochenschr. 1991 Nov 16;121(46):1701-5.
10
Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator.长期胺碘酮治疗对植入式心脏复律除颤器除颤阈值和电击率的影响。
Am Heart J. 1991 Sep;122(3 Pt 1):720-7. doi: 10.1016/0002-8703(91)90517-l.